ZARR

News and price dashboard

Swept 19:36
Sources
27, all reachable
Items
104569
Flagged
12713
Last swept
19:36

STOCKS

121

OPTIONS

25

COMING UP

US majors and your names' earnings, next 7 days

Full calendar

Everything else — unscored, browse only, never pushed

Brief

Oil slide and the Iran headlines driving it

The loudest thing in the feed is crude. Market panels carried inside several of the Investing.com pages show Brent futures at 108.85, down 4.04%, and WTI at 99.71, down 4.24%, with the site's own lead story headlined "FTSE 100 today: Stocks extends slide as oil sinks on hopes of U.S.-Iran talks" and a companion piece on sterling gaining as the dollar slips on Iran diplomacy bets. The same panels show the S&P 500 at 7,580.07, down 1.82%, the Dow down 1.09% at 51,770, the FTSE 100 at 10,702.71, down 0.25%, gold futures up 0.58% at 3,921 and silver up 2.14% at 50.33. Around that, headline-only wires fill in the geopolitics: Iran's IRGC reports an oil tanker struck a naval mine and caught fire in the eastern Strait of Hormuz; separately, Iranian officials have left Doha after indirect talks with Washington while a draft proposal circulates, with Tehran insisting the US naval blockade ends before any final deal. Vitol's CEO is quoted across several headline items saying a correction "could be quite severe" if the US and Iran reach an agreement, that by end-2026 demand will have shrunk by roughly 3 million barrels a day, that it would take a full year for demand to recover to 2025 levels, and that the world cannot cope with a larger disruption than today's. ADNOC's chief says the world has "eroded its supply buffers." All of those are headline-level only, so I can't give you the reasoning behind them beyond what's quoted.

Marvell-Lumentum and the chip backdrop

Two headline items flag Marvell agreeing a $115 billion all-stock deal for Lumentum, framed by Investor's Business Daily as creating an AI connectivity leader. The detail behind the deal isn't in anything I read in full, but a Marvell Form 8K page I did read carries the ticker line MRVL at -10.05%, so the market reaction on Marvell's side was sharply negative on the day. A TradingView headline on LITE notes it testing mid-channel support. Separately, IBD headlines say Check Point fell on a Q3 revenue and billings miss, and NAPCO Security stock tumbled 20% after a fiscal Q1 revenue miss.

KeyBanc cuts three space and defense targets for the same reason

Three notes I read in full, all published within minutes of each other, all cut targets while keeping Overweight ratings, and all cite the same cause: broader sector multiple compression from near-term award timing, the midterm election overhang, and rising rates. Firefly Aerospace goes to $35 from $50, with the shares at $17.93 and down 47% over six months; the note says Alpha Flights 8 and 9 are targeted for Q4 2026 with Flight 9 contingent on Flight 8, most of the 2027 manifest is sold, six lunar missions are awarded including the $144 million Blue Ghost and $75 million MoonFall contracts, and roughly $940 million of liquidity sat on the balance sheet at the end of Q2 2026, so KeyBanc doesn't expect a near-term raise. Intuitive Machines goes to $30 from $38, shares at $10.67 and down 58% over six months, with six awarded missions, Altus-1 launching with IM-3 in Q1 2027 and the remaining four satellites in 2028; the firm frames the Navigation and Space Network Services segment as a bridge from milestone revenue to recurring service revenue. Both notes point to NASA's next Commercial Lunar Payload Services award expected 7 November. AeroVironment goes to $200 from $220, shares at $126.11 after a 66% fall over the past year, with the $465 million Army E-HEL award and LOCUST's first international order cited as strengthening the longer-term counter-UAS case; KeyBanc expects limited FY27 contribution from newer platforms and is watching P550 conversion, Switchblade delivery timing, SCDE backlog and the Salt Lake City capacity expansion, with consensus at $3.24 EPS for FY27 after a trailing loss of $4.07.

SBI Holdings H1 beat

SBI reported H1 FY2026 EPS of 127.63 against a 101.01 forecast, about 26.4% ahead. Revenue was JPY 1,057.5 billion, up 17.2%; pretax profit JPY 324.3 billion, up 52.9%; profit for the period JPY 249.1 billion, up 52.6%; profit attributable to owners JPY 230.6 billion, up 39.1%, with annualised ROE of 23.2%. Financial services did the work, with segment pretax profit above JPY 200 billion for the first time, up 69.7%. SBI SECURITIES passed 17 million Japanese accounts, assets under custody rose 39% to JPY 79 trillion and the investment trust balance rose 49.5% to JPY 32.3 trillion. The dividend was lifted to JPY 80 at year-end, JPY 110 annual. Despite that, the stock was down 1.67% at 2,818.5, roughly 27% off its 52-week high; the write-up attributes the muted reaction to caution over valuation and the sheer spread of projects — digital assets, stablecoins, AI, media, Vietnam expansion, a JPY 50 trillion AUM target by 2030 — rather than anything specific in the numbers.

PCBL Chemical: less volume, better margin

PCBL's Q2 FY2027 showed revenue up 14% to INR 2,474 crore, EBITDA up 12% to INR 310 crore and PAT up 20% to INR 74 crore, with the shares up 2.04% at 282.6. Export carbon black volume fell 18% quarter on quarter, which management said was deliberate — they walked away from low-margin business in Southeast Asia and other spot markets. EBITDA per tonne was about INR 19,800, or INR 17,500 stripping out a INR 2,300 per tonne benefit from a full INR 33 crore US tariff refund. MD Nilesh Gandhi said the 7% volume growth target for FY2027 now looks "a little bit challenging" given raw material availability and competition, while sticking to double-digit growth in average EBITDA per tonne. Project Alchemy is targeting INR 200-250 crore of savings but delivered only INR 10-15 crore in the quarter, with the bulk expected from Q4 FY2027. Aquapharm contributed INR 433 crore revenue and INR 42 crore EBITDA.

United Foodbrands: 41% growth, stock down 5%

Q2 FY27 consolidated revenue rose 40.9% year on year to INR 429 crore with same-store sales up 24.5%, dine-in transaction volume up 56% and delivery up 47%. Growth was entirely volume-led — no price increases in four quarters — which also meant average bill realisation came under pressure as the cheaper Big Buffet format expanded. Mature-store restaurant operating margin was 14.7%, new-store margin 7.4%, gross margin 65.5% and down 30bp sequentially. The store count ended at 274 with a target of 300-plus by FY27-end and a raised FY2030 target of 425-450. The stock fell 5% to 603.3; the article points to the sequential gross margin dip, higher corporate costs and lower bill realisation as the likely reasons.

A thick cluster of analyst target changes, headlines only

Beyond the KeyBanc notes, the feed carries dozens of one-line broker items, most duplicated across Investing.com's UK and news feeds. AbbVie alone draws three separate raises — Bernstein to $275 on pipeline strength, RBC Capital on immunology growth, and Canaccord on pipeline progress. Other raises named: Bernstein on nVent Electric (strong demand), Gilead (strong growth) and Capri to $24 (margin beat); RBC on General Dynamics (submarine strength) and AstraZeneca (strong results); Keefe Bruyette on CBOE (derivatives), First Business Financial and Amerant Bancorp; Guggenheim on Starbucks (strong sales); Piper Sandler on Mid-America Apartment, PBF Energy and Blue Owl. Cuts: Bernstein SocGen on Qualcomm over handset concerns, Keefe Bruyette on Burke & Herbert, and HSBC on Beiersdorf citing slowing Nivea sales and limited margin upside. Evercore ISI upgraded Mohawk Industries to Outperform, D.A. Davidson upgraded Franklin Electric, Stifel reiterated Buy on Repligen at $207, StoneX reiterated Buy on Shopify ahead of earnings and on Qualcomm ahead of results, and Morgan Stanley named CaixaBank a top pick on an expected net interest income rebound. Nasdaq's consensus-target screens add mechanical moves: Freddie Mac preferred down 39.14% to $13.11, Fannie Mae down 22.93% to $6.71, Theriva up 60% to $4.08, West Pharmaceutical up 12.52% to $467.89, among others. None of these carry reasoning beyond the headline.

Everything else is filings and chart posts

The bulk of the remaining feed is regulatory boilerplate — ten Form 8K and Form 4 pages that I read in full and which contain no content whatsoever beyond the filing title and the site's standard market furniture. The only information in them is the ticker move printed on each page: NRX Pharmaceuticals -14.66%, Strive -10.90%, Valion Bio -10.86%, Marvell -10.05%, Veeco -9.18%, FTAI Aviation -4.46%, PROG Holdings +3.79%, Choice Hotels -1.60%, Intrusion -1.69%, Xeris -0.37%, Meta -1.53%. What the filings actually say is not disclosed in any of them. Alongside that sit roughly fifty TradingView chart-opinion posts on gold, Nasdaq, Bitcoin, XRP, Solana, BNB, TRON and crude, which are individual traders' technical views and carry no reported facts. A handful of smaller corporate headlines round it out: Ingersoll Rand acquiring IVEK, Theriva selling its antibiotic-degrading enzyme portfolio to Biossil, Rectitude acquiring Mr. Butler, UroGen dosing its first UGN-501 patient, Enlivex posting positive 12-month knee osteoarthritis data, Syntec Optics citing a 25% increase in space reconnaissance orders, Intrusion completing a $4 million debt-for-equity exchange, Landstar's CEO buying $714,619 of stock, and Blackstone-led investors buying into LNG Canada for $3.1 billion. Strategy's Saylor posted the purchase of 811 BTC for $65.5 million at an average $80,846, taking holdings to 849,327 BTC, alongside $208 million of STRC repurchases and $164 million raised selling 1.18 million MSTR shares. Binance says it is working to resume withdrawals for additional networks with the next phase planned for Tuesday.

19 read in full, 200 items in the section

Feed

158 stories · 158 newCross-publisher stories only
  1. Pinned
  2. 158 new
  3. 11/2/26 - $mrvl - mar-V-ell
    TradingView [COMMENT]
  4. We may bottom tomorrow 745-740
    TradingView [COMMENT]
  5. EUR/USD | WK 45 - 1HR CHART
    TradingView [COMMENT] 3 items
  6. Pampa Energia stock hits 52-week low at 69.32 USD
    Investing.com - news 11 itemsalso Investing.com - UK, Investing.com - news
  7. Mara stock hits 52-week low at $6.44
    Investing.com - news 2 itemsalso Investing.com - UK
  8. Alphabet C gaps down to extreme oversold RSI: Live levels
    Investing.com - news 2 itemsalso Investing.com - UK
  9. Tesla shooting star at $414 signals pullback risk: Live levels
    Investing.com - news 2 itemsalso Investing.com - UK
  10. Penny stock with small float
    TradingView [COMMENT]
  11. Raymond James upgrades Lumentum stock rating on Marvell deal value
    Investing.com - news 2 itemsalso Investing.com - UK
  12. Consumer Portfolio Services shareholders elect board and approve proposals
    Investing.com - news 2 itemsalso Investing.com - UK
  13. Monday 11/2 Insider Buying Report: ATEC, RBBN
    Nasdaq - stocks 2 items
  14. Form 8K Consumer Portfolio Services Inc For: 2 November
    Investing.com - UK 36 itemsalso Investing.com - UK
  15. Form 8K Cottonwood Communities For: 2 November
    Investing.com - UK 10 itemsalso Investing.com - UK
  16. USDCHF: Long Signal Explained
    TradingView [COMMENT]
  17. Monday's ETF with Unusual Volume: FLCG
    Nasdaq - stocks
  18. Safety Insurance Group stock hits all-time high at 104.35 USD
    Investing.com - UK 13 itemsalso Investing.com - news
  19. Monday's ETF Movers: TAN, ARKG
    Nasdaq - stocks
  20. Swing Trade Idea | $BA Short | 2:1 P&L
    TradingView [COMMENT]
  21. Bearish Trend Shift – Downside Targets in Focus
    TradingView [COMMENT] 2 itemsalso TradingView
  22. Bitcoin still far above summer’s lows
    TradingView [COMMENT]
  23. Priceline.com, AMD, Amgen, and more set to report earnings Tuesday
    Investing.com - news 2 itemsalso Investing.com - UK
  24. Manufacturing PMI and JOLTs job openings among economic data due Tuesday
    Investing.com - news 2 itemsalso Investing.com - UK
  25. Form 144 MongoDB For: 2 November
    Investing.com - UK 12 items
  26. Form 144 Hayward Holdings For: 2 November
    Investing.com - UK 3 items
  27. DJI update
    TradingView [COMMENT]
  28. American Water Works stock hits 52-week high at $146.63
    Investing.com - news 2 itemsalso Investing.com - UK
  29. GBPCAD Under Pressure! SELL!
    TradingView [COMMENT]
  30. Grifols Q3 2026 slides: margin expansion drives leverage below 4x
    Investing.com - UK 2 itemsalso Investing.com - news
  31. Form 144 NEWMONT Corp /DE/ For: 2 November
    Investing.com - UK 3 itemsalso Investing.com - UK
  32. BTCUSDT | Bullish Reaction From Key Demand Zone
    TradingView [COMMENT] 2 items
  33. CHFJPY Technical Analysis! SELL!
    TradingView [COMMENT]
  34. EUR/USD – Technical Chart Analysis
    TradingView [COMMENT] 2 items
  35. CSCO Stock: Market Commentary
    TradingView [COMMENT] 3 items
  36. Earnings call transcript: Grifols rises on q3 2026 cash flow and margin gains
    Investing.com - news 2 itemsalso Investing.com - UK
  37. Capital Power Q3 2026 slides: record EBITDA, $1.25B upside potential
    Investing.com - UK 2 itemsalso Investing.com - news
  38. HOW-TO: Four in a row | Reading FAST and RUN
    TradingView [COMMENT]
  39. Gold reaction to London range Sellside
    TradingView [COMMENT]
  40. XAUUSD | 1H/4H Analysis & Trading Strategy |November 3
    TradingView [COMMENT] 3 items
  41. Cipher Mining stock reaffirmed at Buy by H.C. Wainwright on AI demand
    Investing.com - news 2 itemsalso Investing.com - UK
  42. Bullish bounce in play?
    TradingView [COMMENT]
  43. TCW Strategic Income Fund director Rooney disposes of $125,051 in stock
    Investing.com - UK 2 itemsalso Investing.com - news
  44. SP500.r | Multi-Timeframe Technical Analysis
    TradingView [COMMENT]
  45. Edwards PASCAL system shows superiority in tricuspid repair trial
    Investing.com - UK 2 itemsalso Investing.com - news
  46. Earnings call transcript: Information Services Group tops Q3 2026 estimates
    Investing.com - UK 6 itemsalso Investing.com - news
  47. Earnings call transcript: Capital Power misses Q3 2026 estimates, shares steady
    Investing.com - UK 9 itemsalso Investing.com - news
  48. Stifel downgrades Lumentum stock rating on Marvell deal terms
    Investing.com - news 2 itemsalso Investing.com - UK
  49. IGL as on 02.11.2026
    TradingView [COMMENT]
  50. Fitch downgrades Goodyear to B+ as tire volume declines outpace cost cuts
    Investing.com - news 2 itemsalso Investing.com - UK
  51. NAPCO Q1 2027 slides: recurring revenue hits 52% despite earnings miss
    Investing.com - news 2 itemsalso Investing.com - UK
  52. EURUSD | Bullish Pullback Into Demand Zone
    TradingView [COMMENT]
  53. Bearish momentum to continue?
    TradingView [COMMENT]
  54. XAUUSD H4 | Bullish RSI Divergence at 1-Year Low
    TradingView [COMMENT]
  55. B.Riley lowers Marvell stock price target on acquisition concerns
    Investing.com - UK 2 itemsalso Investing.com - news
  56. Bearish drop off?
    TradingView [COMMENT]
  57. XAUUSD ON MSNR
    TradingView [COMMENT]
  58. Coface Q3 2026 slides: services growth accelerates amid rising claims
    Investing.com - UK 2 itemsalso Investing.com - news
  59. Bullish rebound?
    TradingView [COMMENT]
  60. Form 4 Abbott Laboratories For: 2 November
    Investing.com - UK 18 items
  61. GBPUSD | Potential Bearish Continuation From Resistance Zone
    TradingView [COMMENT] 2 items
  62. Plan for 3rd November 2026
    TradingView [COMMENT]
  63. Exclusive: Squarespace layoffs fall mostly on product and engineering
    Investing.com - news 2 itemsalso Investing.com - UK
  64. US500/ SPX500 bias are bullish
    TradingView [COMMENT]
  65. Marvell stock falls on Lumentum deal concerns, William Blair reiterates Outperform
    Investing.com - news 2 itemsalso Investing.com - UK
  66. CL Short
    TradingView [COMMENT]
  67. Why is Intel stock sliding today?
    Investing.com - UK 18 itemsalso Investing.com - news
  68. ETHUSD | Bullish Recovery From Key Demand Zone
    TradingView [COMMENT] 2 items
  69. TSLA 2023 vs. 2026: Breakout or Fake-out?
    TradingView [COMMENT]
  70. Earnings call transcript: COFACE Q3 2026 profit holds firm as growth improves
    Investing.com - news 2 itemsalso Investing.com - UK
  71. Uber Stock Underperforming Ahead of Earnings
    Schaeffer's Research [COMMENT]
  72. Form 144 IRON MOUNTAIN INC For: 2 November
    Investing.com - UK 14 items
  73. Karyopharm stock rating cut to neutral by Rodman on bankruptcy
    Investing.com - news 2 itemsalso Investing.com - UK
  74. Pfizer stock hits 52-week high at 30.68 USD
    Investing.com - UK 13 itemsalso Investing.com - news
  75. EURCAD ,Buy On H4
    TradingView [COMMENT]
  76. EURCHF,Buy On H4
    TradingView [COMMENT]
  77. Del Monte Corporation stock hits 52-week low at 26.45 USD
    Investing.com - news 2 itemsalso Investing.com - UK
  78. Crypto.com to exit Hong Kong consumer app citing operations - Bloomberg
    Investing.com - news 2 itemsalso Investing.com - UK
  79. DeepSeek adds creator mode to boost AI agent tools
    Investing.com - news 2 itemsalso Investing.com - UK